Sales representative in Specialty Medicine Metropolitan 10 at Acadia Pharmaceuticals

Tokyo, Japan

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

MR certification (MR認定証)
Driver's license (運転免許証)
Willingness to transfer nationwide (全国転勤可能な方)
5+ years of MR experience at a pharmaceutical company (製薬企業にて5年以上のMR経験)
Experience handling university hospitals and major large-scale hospitals (大学病院および主要な大規模病院の担当経験)
PC skills (PCスキル)
Preferred (歓迎要件)
Experience in oncology (がん領域の経験)
Experience in urology (泌尿器領域の経験)
Pharmacist qualification (薬剤師資格)

Responsibilities

Provide pharmaceutical information to doctors, nurses, and pharmacists in the assigned area and promote proper use (担当エリア内の医師・看護師・薬剤師に対する医薬品情報の提供と適正使用の推進)
Plan, organize, and operate lectures and seminars (講演会の企画立案および運営)
Grasp on-site needs and liaise with internal related departments (現場ニーズの把握と社内関連部門との情報連携)

Skills

MR Certification

Pharmaceutical Sales

University Hospital Experience

Large Hospital Experience

PC Skills

Driver's License

Oncology

Urology

Seminar Planning

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free